Teleflex Launches New Arrow® VPS® Stylet
February 24 2016 - 5:00PM
Business Wire
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical technologies for critical care and surgery, announced it
has received FDA 510(k) clearance to market a newly designed Arrow®
VPS® Stylet. The new design allows Teleflex to provide hospitals
with a complete offering of single, double and triple lumen
pre-loaded, pressure injectable Arrow® PICC with Chlorag+ard®
Technology for use with its current Arrow® VPS® Device platform.
Together these technologies provide an easy solution for clinicians
who are dedicated to reducing central venous catheter malposition
while helping prevent microbial colonization and thrombus
accumulation on catheter surfaces.
Eliminating chest X-ray, reducing patient exposure to radiation
and providing protection against microbial colonization and
thrombus accumulation on catheter surfaces is easier than ever now
that the single, double and triple lumen Arrow® PICC with
Chlorag+ard® Technology is available pre-loaded with the Arrow®
VPS® Stylet.
The Arrow® VPS® Device is designed to replace the need for
confirmatory chest X-ray in the presence of a steady Blue Bullseye
by using state-of-the-art, real-time intravascular Doppler, ECG and
advanced algorithmic logic to notify the clinician that the
catheter tip has reached the optimal location.
“Vascular access procedures are one of the most commonly
performed in the hospital but are inherently high risk. This has a
major impact on hospital reimbursement under the Affordable
Healthcare Act," said Jay White, President of the Vascular Division
of Teleflex. "We are proud to now provide a full offering of
pre-loaded Arrow® PICC with Chlorag+ard® Technology for use with
our innovative Arrow® VPS® Devices. The combination of these
leading technologies allows us to provide cutting-edge tools to
help improve patient outcomes and help solve problems faced by the
vascular access clinician every day."
Additional information may be found at
www.arrowvascular.com/vps, www.chloragard.com and
www.teleflex.com.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed
to improve the health and quality of people’s lives. We apply
purpose driven innovation – a relentless pursuit of identifying
unmet clinical needs – to benefit patients and healthcare
providers. Our portfolio is diverse, with solutions in the fields
of vascular and interventional access, surgical, anesthesia,
cardiac care, urology, emergency medicine and respiratory care.
Teleflex employees worldwide are united in the understanding that
what we do every day makes a difference. For more information,
please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®,
Pilling®, Rüsch® and Weck® – trusted brands united by a common
sense of purpose.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Chlorag+ard, Deknatel,
Hudson RCI, LMA, Pilling, Rüsch, VPS, VPS G4 and Weck are
trademarks or registered trademarks of Teleflex Incorporated or its
affiliates, in the U.S. and/or other countries.© 2016 Teleflex
Incorporated. All rights reserved. MC-002067
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160224006217/en/
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor Relations610-948-2836
Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024